In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

A panelist discusses how their institution evaluates biosimilars for formulary inclusion through a systematic review process ...

In a new study, researchers found that time-in-range for healthy blood sugar could be a viable marker of glycemic control and potentially could be used to predict complications of type 1 diabetes.

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

This bipartisan legislation prevents further cuts, provides a modest inflationary adjustment to help ease the cost of care, ...

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to ...

The nominee for HHS secretary hedged this answers to questions about vaccine safety and efficacy at his second confirmation hearing today.

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Some regulatory changes are already set to happen this year, but reduced regulation under the new administration could have a ripple effects in healthcare. Meanwhile, artificial intelligence is likely ...